Cite
HARVARD Citation
Baig, H. et al. (2019). Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level. Journal of oncology pharmacy practice. pp. 1576-1585. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Baig, H. et al. (2019). Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level. Journal of oncology pharmacy practice. pp. 1576-1585. [Online].